Emanuel F. Petricoin

Emanuel F. Petricoin has been the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor. The focus of the CAPMM is the invention and use of proteomics technologies for personalized therapy, molecular diagnostics, and biomarker discovery.

He is a co-founder of four life science companies in the nanotechnology-diagnostic and precision medicine space. He has co-authored nearly 400 publications and is a co-inventor on 40 filed and published patents.

He has authored over 45 book chapters, is a Senior Editor for Cancer Epidemiology Biomarkers and Prevention, and is on the editorial board of JCO Precision Oncology, Nature Precision Oncology, Proteomics, Biomedical Microdevices, Proteomics-Clinical Applications, Proteomics-Protocols, Molecular, Carcinogenesis and the Journal of Personalized Medicine. Dr. Petricoin is a founding member of the Human Proteomic Organization (HUPO).

He has received numerous awards including the University Professorship at George Mason University, the NIH Director’s Award, the FDA Distinguished Scientist Award, the 2015 Innovator of the Year Award, the GAP50 Top Virginia Entrepreneurs, Nifty 50 Award, the American Society of Cytopathology Basic Research Award, the Roche Diagnostics/CLAS Distinguished Scientist Award and the Harvard University Leading Edge Award. Dr. Petricoin has been awarded the distinction of a Kentucky Colonel.